Merck’s Mevacor Switch Bid Digs Deeper Into Consumers’ Self-Selection
This article was originally published in The Tan Sheet
Executive Summary
Merck's self-selection study developed to support its latest Mevacor OTC switch application will bolster its bid by providing deeper insight into consumers' selection decisions, the firm says